Results 141 to 150 of about 26,475 (236)

FGFR1 Induces Glioblastoma Radioresistance through the PLC /Hif1  Pathway

open access: yes, 2016
International audienceAbstract FGF2 signaling in glioblastoma induces resistance to radiotherapy, so targeting FGF2/FGFR pathways might offer a rational strategy for tumor radiosensitization.
V. Gouaze-Andersson   +15 more
core   +1 more source

Combining decitabine with radiotherapy to enhance nasopharyngeal carcinoma radiosensitivity via the TFAP2C-OTUD1-SLC25A11 axis

open access: yesCell Death and Disease
Nasopharyngeal carcinoma (NPC) is a common malignancy in certain geographic regions, with radiotherapy serving as the primary treatment. Recent research shows that epigenetics and deubiquitinases (DUBs) are crucial in NPC progression and treatment ...
Haixia Zhang   +13 more
doaj   +1 more source

ACSS1 co-opts acetyl-CoA metabolism to drive DNA repair and undermine radiotherapy efficacy in breast cancer

open access: yesCell Death and Disease
Breast cancer remains a leading cause of cancer-related mortality worldwide, with radiotherapy serving as a cornerstone of treatment. However, the development of radioresistance significantly compromises therapeutic efficacy and patient outcomes. Through
Xiao Fu   +11 more
doaj   +1 more source

Overcoming Cancer Radioresistance Factors of radioresistance in prostate cancer

open access: yesRadiotherapy and Oncology, 2016
Krause, M., Dubrovska, A., Baumann, M.
openaire   +1 more source

Molecular mechanisms of m6A modifications regulating tumor radioresistance

open access: yes
Radiotherapy is one of the most effective treatments for malignant tumors. Radioresistance is a major factor that contributes to radiotherapy failure and poor prognosis. Recent studies have elucidated the pivotal role of aberrant N6-methyladenosine (m6A)
Ruolin Shen   +4 more
core   +1 more source

A three-gene radioresistance signature predicts tumor progression in cervical cancer. [PDF]

open access: yesTransl Cancer Res
Yu H   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy